*Department of Pharmacy, Radboud University Medical Center, Nijmegen;
†Department of Clinical Oncology;
‡Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center;
§Department of Clinical Chemistry, Erasmus Medical Center, Rotterdam;
¶Department of Medical Oncology, Radboud University Medical Center, Nijmegen; and
‖Department of Medical Oncology, Academic Medical Center, University of Amsterdam, the Netherlands.
Correspondence: David M. Burger, PharmD, PhD, Department of Pharmacy, Radboud University Medical Center, Internal Post 864, Geert Grooteplein 10, 6525 GA Nijmegen, the Netherlands (e-mail: [email protected]).
The authors declare no conflict of interest.
CYP2D6 genotyping was performed by the Department of Clinical Chemistry at the Erasmus Medical Center in Rotterdam, the Netherlands. The Department of Clinical Pharmacy and Toxicology at the Leiden University Medical Center, the Netherlands, analyzed the pharmacokinetic samples.
Received July 30, 2014
Accepted January 28, 2015
